Topic: Pharma Immunity

The CDC's advisory committee (ACIP) voted 8-3 to no longer recommend the Hepatitis B vaccine for newborns whose mothers test negative for the virus. This reversal ends a 30-year policy and shifts the decision to a consultation between parents and doctors. The discussion highlights the 1986 immunity clause that protects pharmaceutical companies from liability, questioning why such protection remains necessary if the products are deemed safe.

The segment explores the financial incentives for pediatricians to maintain high vaccination rates within their practices. Claims are made that a significant portion of pediatric income is derived from bonuses tied to full vaccination compliance. The hosts argue that the push for herd immunity is often driven by pharmaceutical profit motives rather than purely clinical outcomes.

Dr. McCullough explains that prior to widespread vaccination, mothers passed natural measles immunity to their infants at birth, protecting them for up to a year. He claims that mothers vaccinated with the MMR vaccine do not pass this protection to their babies, leaving infants more vulnerable than in previous generations.

A federal bankruptcy judge approved a controversial deal allowing the Sackler family to gain immunity from future opioid lawsuits in exchange for a $4 billion payment. The deal allows the family to keep billions of their fortune while stopping hundreds of civil lawsuits. The hosts describe this as a "scam of scams" that protects the family without them personally filing for bankruptcy.

NPR reports on "superhuman immunity" found in individuals who had COVID-19 and then received a vaccine. The discussion questions why media and officials are discouraging the public from looking at data from Israel, which suggests high infection rates among the vaccinated.